{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Iselin",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "75655",
      "recalling_firm": "Nationwide Laboratories, LLC",
      "address_1": "33 Wood Ave S Ste 600",
      "address_2": "",
      "postal_code": "08830-2717",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in USA and Puerto Rico",
      "recall_number": "D-0167-2017",
      "product_description": "Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey  08830, NDC 42937-701-10.",
      "product_quantity": "6,333,669 tablets",
      "reason_for_recall": "CGMP Deviations: manufactured under practices which may result in assay or content uniformity failures.",
      "recall_initiation_date": "20161028",
      "center_classification_date": "20161201",
      "termination_date": "20180517",
      "report_date": "20161207",
      "code_info": "Lot #: 28161501, Exp 03/17; 28161502, 28161503, Exp 08/17; 28161601, 28161602, Exp 01/18",
      "more_code_info": ""
    }
  ]
}